Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131000 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients
A Phase 3 study of Fever, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
- 11
- Study locations
NCT01131000 is a Phase 3 study of Fever that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 123 participants, below the 593-participant average among 18 other Fever trials with a reported enrollment target (79% lower). The trial reports 11 study locations across 8 states.
The verdict
NCT01131000, a Phase 3 study of Fever, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.
Conditions Studied
Interventions
- DRUG Ibuprofen
- OTHER Normal Saline
Study Locations (11)
Tennessee
- Methodist Healthcare - University Hospital - Memphis
- Vanderbilt University Medical Center - Nashville
- Skyline Medical Center - Nashville
North Carolina
- Moses H. Cone Memorial Hospital - Greensboro
- Wake Forest University Health Sciences - Winston-Salem
Florida
- Orlando Regional Medical Center - Orlando
Missouri
- Barnes Jewish Hospital - St Louis
Texas
- Ben Taub General Hospital - Houston
New South Wales
- Newcastle Mater Misericordiae Hospital - New Lambton
South Australia
- Flinders Medical Centre - Adelaide
Other
- Mahidol University Siriraj Hospital - Bangkok
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2002-06 |
| Est. Completion | 2005-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131000
The ClinicalTrials.gov registry entry for NCT01131000 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 593-participant average among 18 other Fever trials with a reported enrollment target (79% lower). The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen is the first listed.
NCT01131000 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Tennessee, North Carolina, Florida.
Frequently Asked Questions
What is clinical trial NCT01131000 about?
NCT01131000 is a clinical study titled "Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients". The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.
What is the current status of trial NCT01131000?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2002-06. Estimated completion is 2005-08.
What conditions does trial NCT01131000 study?
This clinical trial studies the following conditions: Fever.
What interventions are being tested in trial NCT01131000?
The interventions under investigation include: Ibuprofen (DRUG), Normal Saline (OTHER).
Who is sponsoring clinical trial NCT01131000?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01131000 being conducted?
This trial has 11 study locations across Florida, Missouri, North Carolina, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
COMPLETED · Phase 3
-
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
COMPLETED · Phase 3
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
RECRUITING · NA
-
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
RECRUITING · NA
-
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.